- Home
- WAVE vs ATNM Comparison
WAVE vs ATNM Comparison
Compare WAVE & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAVE
- ATNM
- Stock Information
- Founded
- WAVE 2011
- ATNM 2000
- Country
- WAVE Israel
- ATNM United States
- Employees
- WAVE N/A
- ATNM N/A
- Industry
- WAVE Electric Utilities: Central
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- WAVE Utilities
- ATNM Health Care
- Exchange
- WAVE Nasdaq
- ATNM Nasdaq
- Market Cap
- WAVE 46.0M
- ATNM 50.2M
- IPO Year
- WAVE 2021
- ATNM N/A
- Fundamental
- Price
- WAVE $8.23
- ATNM $1.58
- Analyst Decision
- WAVE Strong Buy
- ATNM Strong Buy
- Analyst Count
- WAVE 1
- ATNM 2
- Target Price
- WAVE $15.00
- ATNM $4.50
- AVG Volume (30 Days)
- WAVE 29.5K
- ATNM 116.8K
- Earning Date
- WAVE 11-20-2025
- ATNM 11-13-2025
- Dividend Yield
- WAVE N/A
- ATNM N/A
- EPS Growth
- WAVE N/A
- ATNM N/A
- EPS
- WAVE N/A
- ATNM N/A
- Revenue
- WAVE $168,000.00
- ATNM N/A
- Revenue This Year
- WAVE $325.00
- ATNM N/A
- Revenue Next Year
- WAVE $85.71
- ATNM N/A
- P/E Ratio
- WAVE N/A
- ATNM N/A
- Revenue Growth
- WAVE N/A
- ATNM N/A
- 52 Week Low
- WAVE $4.41
- ATNM $1.03
- 52 Week High
- WAVE $17.63
- ATNM $2.41
- Technical
- Relative Strength Index (RSI)
- WAVE 49.42
- ATNM 42.17
- Support Level
- WAVE $7.50
- ATNM $1.56
- Resistance Level
- WAVE $8.68
- ATNM $1.64
- Average True Range (ATR)
- WAVE 0.52
- ATNM 0.06
- MACD
- WAVE -0.10
- ATNM -0.01
- Stochastic Oscillator
- WAVE 43.90
- ATNM 6.67
About WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.